CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 378 enrolled
Drug / intervention
Hospital-at-home +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04330378
NCT04330378N/ACompleted

A Hospital-at-Home Pilot in Singapore: A Prospective Quasi-Experimental Cohort Study

National University Health System, Singapore·observational·Posted Apr 1, 2020·Updated Jan 9, 2024

In Brief

An observational study evaluating Hospital-at-home and Usual in-hospital care for Hospital-at-home. Completed, enrolled 378 participants across 2 sites.

Detailed Summary

Hospital-at-home models seek to address the impending shortage of hospital beds by reimagining the way we deliver acute hospital-level care - substituting the ward for a patient's home. Such programmes have been well established in other countries such as Australia, Europe and USA to be a less costly way to provide inpatient care as a result of a reduction of fixed costs of building and running hospitals, with equivalent variable costs and comparable clinical outcomes. Acute services are provided at home, including regular visits by doctors, nurses and therapists, intravenous therapy, simple investigations and 24/7 access to doctors. The clinical service is tech-enabled, by remote monitoring and telecommunication technologies. Although overseas experience suggests that hospital-at-home programmes are an effective, safe and scalable substitute for inpatient beds, and promising strategy to meet the bed demands of our ageing population, the outcomes in the local environment is unclear. Singapore has a unique healthcare system compared to primarily insurance driven (USA) or publicly funded (UK and Australia), which favours subsidies of inpatient care compared to community-based care. In addition, cultural beliefs of hospitals as a source of comfort and healing and unfamiliarity with healthcare providers performing home visits may provide unique challenges which may affect outcomes of a hospital-at-home programme in Singapore. In an Asian setting, family and informal caregivers are heavily involved in the care of patients and may pose unique barriers and facilitators to such care at home that may not be evident in similar models in Western countries. This study aims to evaluate the effectiveness, feasibility and processes of a new hospital-at-home programme in Singapore.

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesSingapore

Timeline

N/ACompletedFinished
202120222023202420252026
First PostedApr 1, 2020
Enrollment StartJan 18, 2021
Primary CompletionMay 18, 2023
Study CompletionJun 18, 2023
TodayJul 2, 2026
Enrollment to primary: 2.3 yearsPosted 6.3 years ago

Interventions

Hospital-at-homeother

As per experimental arm

Usual in-hospital careother

As per control arm